Impact of varicella vaccination on health care outcomes in Ontario, Canada: Effect of a publicly funded program?

Vaccine

Volumn 26, Issue 47, 2008, Pages 6006-6012

  Kwong, Jeffrey C ^a,b,c   Tanuseputro, Peter ^a   Zagorski, Brandon ^a   Moineddin, Rahim ^a,b   Chan, Kevin J ^c  

^a INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Health services utilization; Publicly funded vaccination programs; Varicella vaccines

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

ADOLESCENT; ADULT; ARTICLE; CANADA; CHICKENPOX; EMERGENCY WARD; FEMALE; HEALTH CARE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; INFANT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY ANALYSIS; VACCINATION;

ADOLESCENT; ADULT; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; EMERGENCY MEDICAL SERVICES; FEMALE; GOVERNMENT PROGRAMS; HEALTH SERVICES; HERPESVIRUS 3, HUMAN; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INFANT; MALE; MIDDLE AGED; OFFICE VISITS; ONTARIO; PROGRAM EVALUATION; VACCINATION; YOUNG ADULT;

EID: 55049122726     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.08.016     Document Type: Article

References (21)

1. National Advisory Committee on Immunization. National Advisory Committee on Immunization (NACI) update on varicella. Canada Communicable Disease Report 2004;30(February):1-26.
2. Law B., Fitzsimon C., Ford-Jones L., McCormick J., and Riviere M. Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. The Immunization Monitoring Program-Active (IMPACT). Pediatrics 104 July (1 Pt 1) (1999) 7-14
3. Law B., Fitzsimon C., Ford-Jones L., MacDonald N., Dery P., Vaudry W., et al. Cost of chickenpox in Canada: part I. Cost of uncomplicated cases. Pediatrics 104 July (1 Pt 1) (1999) 1-6
4. Seward J.F., Watson B.M., Peterson C.L., Mascola L., Pelosi J.W., Zhang J.X., et al. Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. The Journal of the American Medical Association 287 February (5) (2002) 606-611
5. Centers for Disease Control and Prevention (CDC). Decline in annual incidence of varicella-selected states, 1990-2001. MMWR-Morbidity & Mortality Weekly Report 2003;52(September (37)):884-5.
6. Nguyen H.Q., Jumaan A.O., and Seward J.F. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. New England Journal of Medicine 352 February (5) (2005) 450-458
7. Davis M.M., Patel M.S., and Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics 114 September (3) (2004) 786-792
8. Zhou F., Harpaz R., Jumaan A.O., Winston C.A., and Shefer A. Impact of varicella vaccination on health care utilization. The Journal of the American Medical Association 294 August (7) (2005) 797-802
9. Russell M.L., Svenson L.W., Yiannakoulias N., Schopflocher D.P., Virani S.N., and Grimsrud K. The changing epidemiology of chickenpox in Alberta. Vaccine 23 November (46-47) (2005) 5398-5403
10. Edgar BL, Galanis E, Kay C, Skowronski D, Naus M, Patrick D. The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination. Canada Communicable Disease Report 2007;33(November (11)):1-15.
11. National Advisory Committee on Immunization. National Advisory Committee on Immunization (NACI) Statement on recommended use of varicella virus vaccine. Canada Communicable Disease Report 1999;25(May (ACS 1)):1-16.
12. Ontario Ministry of Health and Long Term Care. Publicly funded immunization schedules for Ontario-February 2005. Queen's Printer for Ontario; February 2005.
13. Naylor C.D., and Slaughter P. Cardiovascular health and services in Ontario: an ICES atlas (1999), Institute for Clinical Evaluative Sciences, Toronto
14. Chan B.T.B., and Schultz S.E. Supply and utilization of general practitioner and family physician services in Ontario (2005), Institute for Clinical Evaluative Sciences, Toronto
15. Tseng H.F., Tan H.F., and Chang C.K. Use of National Health Insurance database to evaluate the impact of public varicella vaccination program on burden of varicella in Taiwan. Vaccine 24 June (25) (2006) 5341-5348
16. Galil K., Pletcher M.J., Wallace B.J., Seward J., Meyer P.A., Baughman A.L., et al. Tracking varicella deaths: accuracy and completeness of death certificates and hospital discharge records, New York State, 1989-1995. American Journal of Public Health 92 August (8) (2002) 1248-1250
17. Gustafson R., and Skowronski D.M. Disparities in varicella vaccine coverage in the absence of public funding. Vaccine 23 May (27) (2005) 3519-3525
18. Statistics Canada. Births and birth rate, by province and territory. http://www40.statcan.ca/l01/cst01/demo04a.htm (accessed April 3, 2008); 2008.
19. Briss P.A., Rodewald L.E., Hinman A.R., Shefer A.M., Strikas R.A., Bernier R.R., et al. Reviews of evidence regarding interventions to improve vaccination coverage in children, adolescents, and adults. The Task Force on Community Preventive Services. American Journal of Preventive Medicine 18 January (1 Suppl.) (2000) 97-140
20. Brisson M., Edmunds W.J., Law B., Gay N.J., Walld R., Brownell M., et al. Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiology and Infection 127 October (2) (2001) 305-314
21. Edmunds W.J., and Brisson M. The effect of vaccination on the epidemiology of varicella zoster virus. Journal of Infection 44 May (4) (2002) 211-219